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Abstract
In general, reactive nitrogen species, like nitric oxide (NO) and peroxynitrite are classified in primary and secondary according its benefic or deleterious effects 
respectively. Multiple benefic roles through the body has been attributed to nitric oxide (NO), a key signaling molecule, which acts as vasodilator relaxing smooth 
muscles of arteries; participates in the blood pressure control; hinders the initiation of inflammation NO liberated from endothelium cells or lymphocytes to 
intravascular corporal fluid enter into erythrocytes through membrane band 3 protein being after captured by deoxyhemoglobin or by oxyhemoglobin. Inside the 
erythrocytes several chemical reactions occur with generation of S-nitrosoglutathione a NO reservoir molecules and NO derivatives (NOx) molecules namely nitrite, 
nitrate and peroxynitrite. The erythrocyte acts as sensor of the tissues oxygen partial pressure and consequently change its oxygen levels lead along with NO contents. 
NO is released through band 3 protein into the blood, at microcirculatory network, in tissues with low oxygen partial pressure. The aim of this mini review was to 
present the erythrocyte signal transduction pathways associated with NO and S-nitrosoglutathione efflux, metabolic behavior of the NO reservoir molecules and 
NO reactive species in human erythrocytes under several biological conditions. For examples, the effects of external amphipathic molecules, fibrinogen, and internal 
manipulation of protein phosphorylation degree and redox status on erythrocyte. NOx, NO and S-nitrosoglutathione efflux levels are herein included. Erythrocyte 
NO efflux evidenced as biomarkers of inflammatory vascular diseases will be herein highlighted.
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Mini review
Nitric oxide (NO) produced by endothelial cells and T-lymphocytes, 
once released  into  the blood circulation, can enter the erythrocyte 
membrane through band 3 protein [1]. Erythrocytes assure the transport 
of oxygen and nitric oxide obtained from the lungs under high values 
of oxygen partial pressure (PaO2) to systemic tissues, with lower PaO2, 
where partially liberated are [2]. The primary erythrocyte function 
concerning the oxygenation tissue is accompanied by the mobilization 
of NO [3]. Thus, once NO reaches the intra-globular compartment 
binds to oxyhemoglobin forming the S-nitrosohemoglobin (SNO-
Hb) molecules and several reactions happen, such as NO reacting 
with the superoxide anion forming peroxynitrite (ONOO−), which 
subsequently yields nitrite and nitrate [4]; all together these molecules 
receive the nomination of NO derivatives (NOx). Nitrate production in 
erythrocytes occurs in the presence of oxygen and oxyhemoglobin and 
can be converted to nitrite by the action of methemoglobin reductase 
[4]. It is also known that erythrocytes may release nitric oxide in the 
microcirculation under low oxygen tension [2]. The efflux of NO from 
erythrocyte occurs through a trans-nitrosylation process involving 
the thiol group of the band 3 protein that receives NO from SNO-Hb 
[4], however the precise transport mechanism is not yet clarified. The 
GSNO efflux from erythrocytes or red blood cells (RBCs) has also been 
observed by us [5]. Using fluorescence microscopy, we observed NO 
inside human erythrocytes after acetylcholine (ACh) stimulation and 
we were the first to quantify the NO efflux from erythrocytes with a 
potentiometer device [4,6]. 
But until now, the majority of the published studies in the literature 
quantified plasma or erythrocyte nitrite but calling it NO. When NO 
was recognized as a vasodilator [7], we question if RBCs deformability 
will be affected by the presence of NO. So, using SpermineNONOate 
(a NO donor) and ACh as stimulator of NO efflux from erythrocytes, 
we observed an increase in RBCs deformability [8]. Opposite effects 
on the oxygen affinity to hemoglobin, experimentally quantified as 
P50, was obtained with ACh and SpermineNONOate with which 
we observed, respectively augmented and impairment P50 values, 
meaning a decrease and an increase in oxygen affinity for hemoglobin 
[8]. The NO donor behavior has an allosteric factor of oxygen affinity 
for hemoglobin, which was later confirmed [9]. Our experimental 
results with erythrocytes showed NO and oxygen efflux in the 
presence of ACh in opposition to NO influx and oxygen binding to 
Hb in the presence of a NO donor [8]. These results are identical 
to the ones described above about the RBCs gas transportation in 
tissues with high and low PaO2 [2]. As far as is known, NO enters 
into erythrocytes and turn out through membrane band 3 protein 
[10]. Erythrocyte membrane band 3 protein contains tyrosine 
residues able to become phosphorylated, by protein tyrosine kinases 
(PTK: p72syk or p53/56lyn), which could be dephosphorylated by 
protein tyrosine phosphatase (PTP). A dynamic balance between 
band 3 phosphorylation and dephosphorylation occurs in normal 
erythrocytes [11]. Both PTK and PTP enzyme activity are dependent 
on the protein kinase C (PKC) activity which phosphorylates both 
enzymes becoming PTP inactive and PTK in an active state [11]. So, 
our studies pursuit to search answers about the signal transduction 
mechanism associated with erythrocyte NO mobilization under 
influence of amphipathic and hydrophilic molecules, protein 
phosphorylation degree and redox status of erythrocytes.
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Nitrogen oxidative species levels and internal proteins of the 
human erythrocytes in health and inflammatory vascular 
diseases
Acetylcholine (ACh) is a ubiquitous molecule produced by 
endothelial cells and T lymphocytes and the mechanism of ACh 
resultant from endothelial cells into blood circulation was recently 
confirmed [4,12]. In erythrocyte membrane we demonstrate a cross 
talk between band 3 protein and acetylcholinesterase (AChE) enzyme 
binding to its natural substrate, ACh or to an inhibitor, velnacrine 
maleate (VM) [13]. It was also confirmed that the active AChE- ACh 
and inactive AChE–VM complexes conformations associated with 
adenylyl cyclase through Giαβ protein result in lower adenylyl cyclase 
(cAMP) production [13]. It was also shown that both enzyme complex 
conformations activate protein kinase C (PKC) which in turn inhibits, 
by phosphorylation, the phosphodiesterase -3 (PDE-3), without 
changes on cAMP concentration [14].
When AChE-ACh enzyme complex occurs in RBCs membrane, 
high levels of NO efflux, nitrite and nitrate concentrations were 
observed in the absence or presence of band 3 phosphorylation induced 
by calpeptin, the inhibitor of PTP [4,14]. Although, the GSNO levels are 
independent of band 3 phosphorylation degree [14].
Higher significant levels of NO efflux from RBCs were achieved 
when band 3 is dephosphorylated by the p72syk inhibitor in the 
presence of the inactive enzyme complex AChE-VM, when compared 
to the AChE-ACh complex [14].
Regarding the nitrite and nitrate levels they are independent of 
band 3 phosphorylation degree when the AChE-VM inactive complex 
is present in the RBCs membrane [14].
Both PTK and PTP enzymes are also phosphorylated by protein 
kinase C (PKC) resulting in PTP inactivation and PTK activation [11]. 
When RBCs present a higher band 3 protein phosphorylation status, 
this is followed by an increased AChE enzyme activity [13].
When the band 3 protein phosphorylation results from the presence 
of a PKC activator, high values of NO efflux are obtained with AChE-
ACh, at variance of lower values verified under PKC inhibition [5,15]. 
These results reinforce the association between band 3 phosphorylation 
and NO efflux from erythrocytes and confirm the role of cAMP levels 
in the signal transduction pathway; its involvement is dependent of 
PKC activators or inhibitor concentration by direct manipulation in 
erythrocytes.
The NO efflux from erythrocytes measured in the presence of 
AChE-VM was lower in relation to those determined in the presence 
of AChE-ACh [14]. In erythrocytes the inactive AChE-VM enzyme 
complex yield lower nitrite and nitrate levels than those quantified with 
AChE-ACh complex [4,14].
We verified decreased amounts of GSNO and peroxynitrite inside 
erythrocytes when, on its membrane, AChE-ACh active complex was 
present, in relation to the values obtained when the inactive complex 
ACh-VM is formed [14]. Lower GSNO concentration in erythrocytes 
may result from lower glutathione (GSH) content. Reduced free GSH 
inside RBCs can be a consequence of lower reduced potential in the 
form of nicotinamide adenine dinucleotide phosphate concentration, a 
biomarker of the lower oxidative phase of phosphopenthose pathway; 
or from the existence of GSNO efflux from erythrocytes. We have 
shown that no variations are induced by both AChE-ACh and ACHE-
VM complexes in glucose-6-phosphodehydrogenase, glyceraldehyde-
3-phosphate dehydrogenase enzyme activities neither on 2,3- 
bisphosphoglycerate and L-lactate concentrations [14].
We are the former to measure GSNO liberated by erythrocytes in 
the presence of ACh [5]. So, the complex AChE-ACh induces GSNO 
efflux and contributes to lower the levels inside erythrocyte in relation 
to those obtained with the inactive complex AChE-VM [5,14].
When changes on AChE molecular conformations were induced 
by antibodies against the C or N terminus decreased amounts of GSNO 
and NO efflux from erythrocytes were obtained [13].
The variation of erythrocyte NO efflux, peroxynitrite and GSNO 
levels observed in the presence of velnacrine and ACh called our 
attention to investigate the NO metabolism in a set of redox status 
modulation. At that time, we studied the effects of dithiothreitol 
(DTT; a thiol reducing compound) to function as a thiol (SH) donor. 
It is known that SH groups are easily kept in the reduced state once 
a second thiol is added, such as cysteine or glutathione because they 
rapidly exchange disulfide groups. RBCs in the presence of DTT show 
significantly internal NO dependent reactions originating an increase 
in nitrite, nitrate and GSNO concentrations and a decrease on the NO 
efflux from erythrocytes. Peroxynitrite levels remained unchanged with 
AChE-ACh or AChE –VM enzyme complexes in the presence of DTT, 
but the levels of nitrite and nitrate molecules decreased. Significantly 
increased peroxynitrite concentrations were found in RBCs AChE-
VM plus DTT 1µM and plus DTT 50 µM but lower plus DTT 10 µM 
[16]. We concluded that dithiothreitol induces activation of erythrocyte 
thiol status by decreasing NO efflux and allowing intracellular NO 
mobilization into different derivative molecules, both in the absence and 
presence of the AChE-ACh and AChE-VM enzyme complexes [16].
Beyond the hemostasis properties of fibrinogen (Fib), this protein is 
a hemorheological promoter of RBCs aggregation and plasma viscosity 
[17]. Fibrinogen is also known as one of the acute phase protein 
associated with inflammatory conditions [18]. Fib binds to erythrocyte 
CD47 and at a normal range of concentrations is able to decrease NO 
efflux [19,20].
But high levels of Fib, observed in inflammatory diseases, have 
shown an increase in NO efflux from RBCs in dependence of the band 
3 protein phosphorylation and lower levels of cAMP [20] (Figure 1).
Previously we verify an increased AChE enzyme activity in patients 
with glaucoma under timolol maleate therapy for reducing increased 
intra-ocular pressure and we evidenced that timolol is a weak inhibitor 
of erythrocyte AChE [21]. When the less active complex AChE-timolol 
is formed in erythrocytes obtained from healthy donors, lower NO 
efflux and lower S-GSNO levels in erythrocytes compared with the 
active complex AChE-ACh were found [22]. The RBCs of glaucoma 
patients without timolol therapy are able to liberate the same amount 
of NO and have equal GSNO levels that are obtained after incubation 
with timolol [23].
Erythrocyte NO availability as a marker of inflammatory 
vascular diseases
When the less active complex AChE-timolol is formed in 
erythrocytes obtained from glaucoma patients higher NO efflux and 
GSNO content were observed in relation to those assessed in RBCs 
from healthy humans [23]. In this painful and progressive ocular 
disease the decrease ability to preserve NO inside the RBCs may be a 
deleterious nitrogen reactive species contributing to worse the vascular 
endothelial dysfunction.
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In two groups of patients’ one with systemic lupus erythematosus 
and the other with rheumatoid arthritis, characterized by subclinical 
atherosclerosis, the NO efflux values obtained from their erythrocytes 
associate negatively with carotid intima-media thickness (cIMT) and 
with the presence of plaques and NO efflux is an independent predictor 
of cIMT [24]. In these immune diseases NO may be considered a primary 
nitrogen reactive species resulting from its rescue inside the RBCs.
Another painful and mortal disease in small years after appearance 
with very rare exceptions is amyotrophic lateral sclerosis (ALS) [25]. 
RBCs of these patients showed higher AChE enzyme activity, lower 
nitrite concentrations and lower NO efflux from RBCs than those 
obtained in healthy humans; higher NO quartiles values associated 
with worse respiratory function; positive relation between quartile 
values were obtained between AChE enzyme activity and nitrites [25]. 
The discrepancy between the active state of AChE enzyme and lower 
NO efflux observed in the blood samples of the ALS patients must be 
explored in future studies. But we hypothesized that these biochemical 
parameters can be considered as biomarkers of ALS disease [25]. 
Also in sepsis, some studies have regarded the erythrocyte NO 
availability. But besides a lot of research that has been done in all 
classes of sepsis it is insufficient due to the high level of mortality of this 
disease. We verify in a follow-up study conducted in an intensive care 
unit (ICU) that patients with septic shock, that died, showed higher 
efflux of NO from RBCs than the survivors. The NO may combine 
with oxygen anion peroxide produced by the dysfunctional vascular 
endothelium originating peroxynitrite; this is a secondary nitrogen 
reactive species with deleterious effects on all blood components and a 
marker of inflammation. Moreover, blood flow and high microvascular 
flow index were observed in those septic patients before dead with a 
device to follow and measured the hemodynamic parameters in sub-
lingual microcirculation [26].
Conclusions
The erythrocyte nitrogen reactive species were evidenced to be 
dependent on circulating acetylcholine, fibrinogen and inhibitors of 
acetylcholinesterase, redox thiol status, protein degree phosphorylation 
and cAMP levels. Erythrocyte NO efflux and AChE may be considered 
as biomarkers of inflammatory vascular diseases.
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